GMDA News and Press, Gamida Cell Ltd. From 05/21/20

Gamida Cell Ltd. (GMDA) Q1 2020 Results Conference Call May 21, 2020 08:30 AM ET Company Participants Jaren Madden - Vice President, Investor Relations and Corporate Communications Julian Adams - CEO Ronit Simantov - Chief Medical Officer Shai Lankry - CFO Conference Call Pa...

Gamida Cell (NASDAQ: GMDA ): Q1 GAAP EPS of -$0.31 beats by $0.15 . More news on: Gamida Cell Ltd., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

– Primary endpoint achieved in global, randomized, Phase 3 study of omidubicel; Initiation of BLA submission planned for fourth quarter of 2020 — – Additional data from GDA-201 program expected in second half of 2020 – – $60 million follow-on of...

Gamida Cell (NASDAQ: GMDA )  -25%  after pricing equity offering. More news on: Gamida Cell Ltd., Gossamer Bio, Inc., Bellerophon Therapeutics, Inc., Stocks on the move, , Read more ...

Gamida Cell (NASDAQ: GMDA ) prices 13,333,334 ordinary shares at a $4.50 per share for aggregate gross proceeds of ~$60M. More news on: Gamida Cell Ltd., Healthcare stocks news, , Read more ...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced the pricing of an underwritten public offering of 13,333,334 ordinary shares at a public offering price of $4.50 per share for aggregate g...

Gainers: ABUS   +46.5% .   DAC   +10.1% . TNP   +9.1% . BIDU   +8.9% . ACB   +6.4% . More news on: Arbutus Biopharma Corporation, Danaos Corporation, Tsakos Energy Navigation Limited, Stocks on the move, , Read more ...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Thursday, May 21, 2020, at 8:30 a.m. ET to review its first quarter 2020 fi...

Vir Bio Moves Ahead with COVID Projects, Reports Higher Q1 Revenue Vir Biotechnology ( VIR ) provided an update about its COVID projects, while confirming GlaxoSmithKline's ( GSK ) investment worth $250 million. The company is currently working on multiple clinical programs to address C...

SIFCO (NYSEMKT: SIF ) +61%  on Q2 results . More news on: SIFCO Industries, Inc., United Natural Foods, Inc., Cyclacel Pharmaceuticals, Inc., Stocks on the move, , Read more ...